These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 39414874)
1. Long-term efficacy of drug-coated balloon-based treatment for de novo left anterior descending artery disease. Kang DO; Kim S; Kim B; Her AY; Shin ES Sci Rep; 2024 Oct; 14(1):24260. PubMed ID: 39414874 [TBL] [Abstract][Full Text] [Related]
2. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery. Gitto M; Sticchi A; Chiarito M; Novelli L; Leone PP; Mincione G; Oliva A; Condello F; Rossi ML; Regazzoli D; Gasparini G; Cozzi O; Stefanini GG; Condorelli G; Reimers B; Mangieri A; Colombo A Circ Cardiovasc Interv; 2023 Dec; 16(12):e013232. PubMed ID: 37874646 [TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease. Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions]. Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271 [No Abstract] [Full Text] [Related]
5. Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial. Gao C; He X; Ouyang F; Zhang Z; Shen G; Wu M; Yang P; Ma L; Yang F; Ji Z; Wang H; Wu Y; Fang Z; Jiang H; Wen S; Liu Y; Li F; Zhou J; Zhu B; Liu Y; Zhang R; Zhang T; Wang P; Liu J; Jiang Z; Xia J; van Geuns RJ; Capodanno D; Garg S; Onuma Y; Wang D; Serruys PW; Tao L; Lancet; 2024 Sep; 404(10457):1040-1050. PubMed ID: 39236727 [TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B; Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854 [TBL] [Abstract][Full Text] [Related]
7. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease. Her AY; Shin ES; Kim S; Kim B; Kim TH; Sohn CB; Choi BJ; Park Y; Cho JR; Jeong YH Cardiovasc Diabetol; 2023 May; 22(1):120. PubMed ID: 37210516 [TBL] [Abstract][Full Text] [Related]
8. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design. Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951 [TBL] [Abstract][Full Text] [Related]
9. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels. Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036 [TBL] [Abstract][Full Text] [Related]
10. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation. Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620 [TBL] [Abstract][Full Text] [Related]
11. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease. Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615 [TBL] [Abstract][Full Text] [Related]
12. Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment. Mitsui K; Lee T; Miyazaki R; Hara N; Nagamine S; Nakamura T; Terui M; Okata S; Nagase M; Nitta G; Watanabe K; Kaneko M; Nagata Y; Nozato T; Ashikaga T Catheter Cardiovasc Interv; 2023 Jul; 102(1):11-17. PubMed ID: 37210618 [TBL] [Abstract][Full Text] [Related]
13. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients. Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267 [TBL] [Abstract][Full Text] [Related]
14. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions. Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B; Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360 [TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions. Venetsanos D; Lawesson SS; Panayi G; Tödt T; Berglund U; Swahn E; Alfredsson J Catheter Cardiovasc Interv; 2018 Nov; 92(5):E317-E326. PubMed ID: 29481718 [TBL] [Abstract][Full Text] [Related]
17. Feasibility and Safety of Drug-Coated Balloon-Only Angioplasty for De Novo Ostial Lesions of the Left Anterior Descending Artery: Two-Center Retrospective Study. Li C; Ding X; Wang L; Li K; Yang X; Liu L; Xu L Front Cardiovasc Med; 2022; 9():874394. PubMed ID: 35548415 [TBL] [Abstract][Full Text] [Related]
18. Comparison of drug-eluting stents vs. drug-coated balloon after rotational atherectomy for severely calcified lesions of nonsmall vessels. Iwasaki Y; Koike J; Ko T; Funatsu A; Kobayashi T; Ikeda T; Nakamura S Heart Vessels; 2021 Feb; 36(2):189-199. PubMed ID: 32857188 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison. Iwańczyk S; Lazar FL; Onea HL; Pesenti N; Wańha W; Woźniak P; Gościniak W; Prof ML; Cortese B Int J Cardiol; 2024 Nov; 415():132436. PubMed ID: 39153511 [TBL] [Abstract][Full Text] [Related]
20. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial. Rubini Gimenez M; Scheller B; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Cattaneo M; Gilgen N; Kaiser C; Jeger RV Clin Res Cardiol; 2024 Jul; 113(7):959-966. PubMed ID: 37495797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]